30 results match your criteria: "CTO Andrea Alesini Hospital[Affiliation]"

The measurement of Calcitonin (Ctn) in fine-needle aspiration (FNA) washout fluids (FNA-Ctn) has demonstrated excellent sensitivity, significantly higher than FNA cytology, in detecting medullary thyroid carcinoma (MTC). However, the absence of a fixed cutoff value for FNA-Ctn poses a limitation. This study aimed to investigate whether the sensitivity of FNA-Ctn in detecting MTC varies with different cutoffs reported in the literature.

View Article and Find Full Text PDF

Clinical management of indeterminate thyroid nodules needs to be revisited. New evidence for a personalized approach to the problem.

J Endocrinol Invest

December 2024

Endocrinology Section, Department of Clinical and Experimental Medicine, Garibaldi Nesima Hospital, University of Catania, Catania, Italy.

Purpose: Thyroid nodules diagnosed by fine needle aspiration cytology (FNAC) as TIR3A or Class III subgroup "other types of atypia" (indeterminate thyroid nodules - ITNs), are the only ones without a unique clinical action indicated for management. This leads to multiple FNAC repetitions (FNAC-reps) and lifelong follow-up, with huge consumption of time and resources. The aims of the study were to inquire the usefulness of repeating FNAC in ITNs and perform an evaluation of a long-term follow-up of a large cohort of ITNs.

View Article and Find Full Text PDF

Aim: The current study aimed to evaluate the effectiveness of peripheral blood mononuclear cells (PB-MNCs) therapy for patients with ischaemic diabetic foot ulcers (DFUs) treated through indirect revascularization.

Methods: The study is a prospective non-controlled observational study including patients with neuro-ischaemic DFUs who received indirect peripheral revascularization and showed a persistence of wound ischaemia defined by the absence of angiographic collateral vessels and TcPO2 values < 30 mmHg in the wound angiosome area. All patients received 3 cycles of PB-MNCs therapy administered along the wound related artery based on the angiosome theory.

View Article and Find Full Text PDF

Thyroid Hormone Resistance: A 17-Year Follow-up Case Report.

Endocr Metab Immune Disord Drug Targets

August 2024

Division of Endocrinology and Diabetes, CTO Andrea Alesini Hospital, Department of Biomedicine and Prevention, University Tor Vergata, 00133, Rome, Italy.

Background: Resistance to thyroid hormone is a rare syndrome characterized by peripheral resistance to thyroid hormones. It is caused by genetic dysfunction of thyroid receptor genes, with Thyroid hormone Receptor-beta (TRβ) being the most prevalent. Affected patients show high thyroid hormone levels and non-suppressed Thyroid-stimulating Hormone (TSH).

View Article and Find Full Text PDF

Severe Hypocalcemia Occurring During the Hospitalization of a Patient Affected by Permanent Post-Surgical Hypoparathyroidism with Multimorbidity: A Case Report.

Endocr Metab Immune Disord Drug Targets

August 2024

Division of Endocrinology and Diabetes, CTO Andrea Alesini Hospital, Department of Biomedicine and Prevention, University Tor Vergata, 00133Rome, Italy.

Article Synopsis
  • * A 63-year-old man with post-surgical hypoparathyroidism was hospitalized for a complication related to his cardiac device, during which he experienced severe hypocalcemia and critical heart changes due to poorly managed therapy.
  • * Consistent and precise long-term treatment with calcium and calcitriol is crucial for maintaining health in hypoparathyroid patients, especially when they have other health problems or face acute medical situations.
View Article and Find Full Text PDF

The aim of the current study was to evaluate the outcomes of patients with diabetic foot osteomyelitis (DFO), comparing subjects with and without peripheral arterial disease (PAD). The study is a prospective study including a population of patients affected by a DFO located in the forefoot. All patients were managed by a surgical conservative approach defined by the removal of the infected bone, in association with the antibiotic therapy.

View Article and Find Full Text PDF

Prevalence of Diabetes Mellitus and Clinical Differences in Patients with Severe Osteoporosis and Fragility Fractures.

J Clin Med

May 2024

Division of Endocrinology and Diabetes, CTO Andrea Alesini Hospital, Department of Biomedicine and Prevention, University Tor Vergata, 00133 Rome, Italy.

Article Synopsis
  • - The study examines the prevalence of diabetes mellitus (DM) among patients with osteoporosis and fragility fractures, finding a prevalence rate of 12.7% among the 589 patients analyzed.
  • - Patients with DM exhibited more combinations of vertebral and hip fractures and had a higher proportion of males, but their bone mineral density (BMD) was higher compared to those without DM.
  • - Interestingly, while BMD was better in the DM group, their trabecular bone score (TBS) was significantly lower, suggesting that TBS may serve as a more reliable indicator of bone health in these patients than BMD.
View Article and Find Full Text PDF

Adequate compliance with wearing therapeutic footwear (TF) to prevent diabetic foot ulcers is known to be low. The primary aim of this study was to identify population awareness about the ulceration and/or recurrence risk according to footwear choice. The secondary aim was to evaluate the compliance level in footwear choice based on a patient's own risk.

View Article and Find Full Text PDF

Early Treatment of Acute Stage 0/1 Diabetic Charcot Foot Can Avoid Major Amputations at One Year.

J Clin Med

March 2024

Division of Endocrinology and Diabetology, Department of Medical Sciences, Fondazione Policlinico "Tor Vergata", 00133 Rome, Italy.

Article Synopsis
  • - The study analyzed diabetic patients with Charcot neuro-osteoarthropathy (CNO), a serious complication of diabetes, being treated at a specialized diabetic foot clinic from early 2019 to late 2022.
  • - Out of 43 patients, the average age was around 57, predominantly male, and most had type 2 diabetes for over 20 years, with a significant portion also having peripheral artery disease.
  • - Results showed a high remission rate of 93% after treatment, with an average remission time of about 5.6 months, and very low rates of major amputations (2.3%) or surgical interventions (7%).
View Article and Find Full Text PDF

Papillary thyroid carcinoma: ≤ 10 mm does not always mean pN0. A multicentric real-world study.

Updates Surg

June 2024

Servizio Di Endocrinologia E Diabetologia, Ospedale Regionale Di Lugano, Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland.

The incidence of papillary thyroid carcinoma (PTC) is increasing and PTC ≤ 10 mm (PTMC) accounts for most new diagnoses. PTMCs are not always low risk, as detection of lymph nodes metastasis (LNM) may occur. The purpose of the study was to analyze the clinical pattern, frequency, and independent risk factors of patients with PTMC and LNM.

View Article and Find Full Text PDF

Diabetic Polyneuropathy and Physical Activity in Type 1 Diabetes Mellitus: A Cross-Sectional Study.

J Clin Med

October 2023

Division of Endocrinology and Diabetes, CTO Andrea Alesini Hospital, Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy.

Background: The purpose of this study is to access whether a personal attitude to physical activity (PA) may influence the appearance of diabetic polyneuropathy (DPN) patients with well-controlled type 1 diabetes mellitus.

Methods: Ninety patients attending the diabetes technology outpatient clinic were enrolled. DPN was investigated according to the Toronto consensus diagnostic criteria.

View Article and Find Full Text PDF

The current study aimed to evaluate the effectiveness of peripheral blood mononuclear cell (PB-MNC) therapy as adjuvant treatment for patients with diabetic foot ulcers (DFUs) and no-option critical limb ischaemia (NO-CLI). The study is a prospective, noncontrolled, observational study including patients with neuro-ischaemic DFUs and NO-CLI who had unsuccessful revascularization below the ankle (BTA) and persistence of foot ischaemia defined by TcPO2 values less than 30 mmHg. All patients received three cycles of PB-MNC therapy administered through a "" in the affected foot along the wound-related artery according to the angiosome theory.

View Article and Find Full Text PDF

Background: The underlying mechanisms of papilledema associated with intracranial hypertension remain unclear. A case of bilateral papillary edema in a patient with chronic idiopathic intracranial hypertension who was asymptomatic during her two pregnancies is reported. .

View Article and Find Full Text PDF

Aims: The current study aims to evaluate the effectiveness of a multidisciplinary diabetic foot team (MDFT) in the management of in-patients affected by diabetic foot problems.

Materials And Methods: The study was a retrospective observational study. Consecutive patients with a diabetic foot problem requiring hospitalisation were included.

View Article and Find Full Text PDF

Prolonged clinical remission of type 1 diabetes sustained by calcifediol and low-dose basal insulin: a case report.

Immunotherapy

September 2023

CTO Andrea Alesini Hospital, Division of Endocrinology & Diabetes, Department of Systems Medicine, University of Rome Tor Vergata, Via San Nemesio 21, Rome, 00145, Italy.

Herein, we describe an unusually prolonged duration (31 months) of the clinical remission phase in a 22-year-old Italian man with new-onset type 1 diabetes. Shortly after the disease diagnosis, the patient was treated with calcifediol (also known as 25-hydroxyvitamin D3 or calcidiol), coupled with low-dose basal insulin, to correct hypovitaminosis D and to exploit the anti-inflammatory and immunomodulatory properties of vitamin D. During the follow-up period, the patient retained a substantial residual β-cell function and remained within the clinical remission phase, as evidenced by an insulin dose-adjusted glycated hemoglobin value <9.

View Article and Find Full Text PDF

Evaluation of the Performance of ACR TI-RADS Also Considering Those Nodules with No Indication of FNAC: A Single-Center Experience.

J Clin Med

January 2023

Division of Endocrinology and Diabetes, CTO Andrea Alesini Hospital, Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy.

Article Synopsis
  • Several risk stratification score systems for evaluating thyroid nodules exist, and this study aimed to assess the effectiveness of the American College of Radiology TI-RADS in distinguishing malignancy among nodules.
  • The research involved 830 nodules, with a significant percentage of those categorized as suspicious (TIR3B/TIR4/TIR5) ultimately proving to be cancerous after surgery.
  • The results suggest that the ACR TI-RADS guidelines for fine needle aspiration cytology (FNAC) may need to be updated, particularly to include more cases classified as TR4 nodules for further evaluation.
View Article and Find Full Text PDF
Article Synopsis
  • The study assessed the prevalence and outcomes of Charcot neuro-arthropathy (CN) in patients with and without peripheral arterial disease (PAD), identifying 76 patients with acute CN.
  • Among the findings, 31.6% of patients had neuro-ischaemic CN, revealing that these individuals were older and had more severe health complications compared to those with neuropathic CN.
  • Results indicated that patients with neuro-ischaemic CN had worse outcomes, such as higher rates of minor/major amputations and hospitalization, highlighting the significant impact of PAD on neuro-arthropathy complications.
View Article and Find Full Text PDF

Background: Cell therapy with autologous peripheral blood mononuclear cells (PB-MNCs) may help restore limb perfusion in patients with diabetes mellitus and critical limb-threatening ischemia (CLTI) deemed not eligible for revascularization procedures and consequently at risk for major amputation (no-option). Fundamental is to establish its clinical value and to identify candidates with a greater benefit over time. Assessing the frequency of PB circulating angiogenic cells and extracellular vesicles (EVs) may help in guiding candidate selection.

View Article and Find Full Text PDF

BNT162b2 mRNA COVID-19 Vaccine Does Not Impact the Honeymoon Phase in Type 1 Diabetes: A Case Report.

Vaccines (Basel)

July 2022

CTO Andrea Alesini Hospital, Division of Endocrinology and Diabetes, Department of Systems Medicine, University of Rome Tor Vergata, Via San Nemesio 21, 00145 Rome, Italy.

Type 1 diabetes (T1D), which is caused by the autoimmune destruction of insulin-secreting pancreatic beta cells, represents a high-risk category requiring COVID-19 vaccine prioritization. Although COVID-19 vaccination can lead to transient hyperglycemia (vaccination-induced hyperglycemia; ViHG), its influence on the course of the clinical remission phase of T1D (a.k.

View Article and Find Full Text PDF

Below-the-ankle arterial disease: a new marker of coronary artery disease in patients with diabetes and foot ulcers.

Acta Diabetol

October 2022

CTO Andrea Alesini Hospital, Division of Endocrinology and Diabetes Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.

Aim: The aim of the current study is to evaluate the association between below-the-ankle (BTA) arterial disease and coronary artery disease (CAD) in patients with diabetic foot ulcers (DFUs).

Methods: The study group was composed of patients with an active neuro-ischaemic DFUs managed in a tertiary care diabetic foot clinic. All patients received a pre-set limb salvage protocol including lower limb revascularization.

View Article and Find Full Text PDF

Among the tools useful for the management of neuropathic pain, ultrasound presents several advantages, shown by the literature. We assessed the scientific production about neuropathic pain and ultrasound from different points of view: general topics, journal categories, geographical origin and lexical analysis. We searched papers on PubMed using the Medical Subject Headings "neuropathic pain" AND "ultrasound".

View Article and Find Full Text PDF

Pedunculopontine tegmental Nucleus-evoked prepulse inhibition of the blink reflex in Parkinson's disease.

Clin Neurophysiol

October 2021

Department of Biotechnological and Applied Clinical Sciences (DISCAB), University of L'Aquila, Via Vetoio Coppito 2, 67100 L'Aquila, Italy.

Objective: To investigate the effects on the blink reflex (BR) of single stimuli applied to the pedunculopontine tegmental nucleus (PPTg).

Methods: The BR was evoked by stimulating the supraorbital nerve (SON) in fifteen patients suffering from idiopathic Parkinson's disease (PD) who had electrodes monolaterally or bilaterally implanted in the PPTg for deep brain stimulation (DBS). Single stimuli were delivered to the PPTg through externalized electrode connection wires 3-4 days following PPTg implantation.

View Article and Find Full Text PDF

Combination of vitamin D and dipeptidyl peptidase-4 inhibitors (VIDPP-4i) as an immunomodulation therapy for autoimmune diabetes.

Int Immunopharmacol

June 2021

Diabetes Research Institute Federation (DRIF), Division of Endocrinology and Diabetes, CTO Andrea Alesini Hospital, ASL Roma 2, Department of Systems Medicine, University of Rome Tor Vergata, Via San Nemesio 21, 00145 Rome, Italy; UniCamillus, Saint Camillus International University of Health Sciences, Via di Sant'Alessandro, 8, 00131 Rome, Italy; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Via San Nemesio 21, 00145 Rome, Italy. Electronic address:

Type 1 diabetes (T1D) and latent autoimmune diabetes in adults (LADA) represent the most common types of autoimmune diabetes and are characterized by different age of onset, degrees of immune-mediated destruction of pancreatic beta cells and rates of disease progression towards insulin dependence. Several immunotherapies aimed to counteract autoimmune responses against beta cells and preserve beta-cell function are currently being investigated, particularly in T1D. Preliminary findings suggest a potential role of combination therapy with vitamin D and dipeptidyl peptidase-4 (DPP-4) inhibitors (VIDPP-4i) in preserving beta-cell function in autoimmune diabetes.

View Article and Find Full Text PDF